Terms: = Uterine cancer AND PDCD1, CD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1 AND Staging
4 results:
1. Relationships between intravoxel incoherent motion parameters and expressions of programmed cell death-1 (pd-1) and programmed cell death ligand-1 (PD-L1) in patients with cervical cancer.
Liu KH; Yang W; Tian HP
Clin Radiol; 2024 Feb; 79(2):e264-e272. PubMed ID: 37926648
[TBL] [Abstract] [Full Text] [Related]
2. Development and Clinical Validation of Novel 8-Gene Prognostic Signature Associated With the Proportion of Regulatory T Cells by Weighted Gene Co-Expression Network Analysis in uterine Corpus Endometrial Carcinoma.
Liu J; Geng R; Yang S; Shao F; Zhong Z; Yang M; Ni S; Cai L; Bai J
Front Immunol; 2021; 12():788431. PubMed ID: 34970268
[TBL] [Abstract] [Full Text] [Related]
3. Treatment of gestational trophoblastic disease in the 2020s.
Clark JJ; Slater S; Seckl MJ
Curr Opin Obstet Gynecol; 2021 Feb; 33(1):7-12. PubMed ID: 33337613
[TBL] [Abstract] [Full Text] [Related]
4. Immunoscore system combining CD8 and pd-1/PD-L1: A novel approach that predicts the clinical outcomes for cervical cancer.
Chen H; Xia B; Zheng T; Lou G
Int J Biol Markers; 2020 Mar; 35(1):65-73. PubMed ID: 31808707
[TBL] [Abstract] [Full Text] [Related]
